EUVIMEDOpdag EUVIMED
VergleichsstudieOpen access · CC BY 4.0

Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow

Arnik Shah iD, Parth Shah, Alex Johnson, Jean Bender, Dmitry Gumerov, Jingwen Ding, Scott Mack, Matthew D Stone, Maggie A Ostrowski

Journal of the American Society for Mass Spectrometry · 2025

DOI: 10.1021/jasms.5c00058 ↗

At a glance

Vergleichsstudie in Journal of the American Society for Mass Spectrometry, 2025. Written by Arnik Shah and 8 co-authors. Institution: Visterra Inc, 275 second avenue, Waltham, Massachusetts 02451, United States. Major MEDLINE topics: Antibodies, Monoclonal, Mass Spectrometry. Cited 3 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: Visterra Inc..

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Accurate characterization of charge variants in biologics is crucial to uphold stringent quality standards ensuring the safety and efficacy of biotherapeutic products and regulatory requirements for the Biologic Licensing Application (BLA) process enabling marketing application. These variants, arising from post-translational modifications (PTMs) during upstream processing and enzymatic/nonenzymatic reactions in downstream processing and storage, can significantly impact therapeutic potency, efficacy, and immunogenicity. Conventional methods for characterizing charge variants typically involve labor-intensive fraction enrichment, consuming time and resources. However, recent technological advancements, exemplified by the Intabio ZT system's innovative platform, enable the seamless and direct integration of imaged capillary isoelectric focusing (icIEF) and UV quantitation with mass spectrometry (MS) PTM identification, facilitating rapid and unbiased characterization. In this study, we conduct a comparative assessment of the charge variant characterization of investigative mAb-1 using icIEF-UV/MS analysis and a traditional fractionation-based workflow. Our results demonstrated that icIEF-UV/MS-based proteoform characterization provided comparable icIEF-UV separation and quantitation and superior direct MS-based peak characterization with shorter time and less sample processing compared to conventional fractionation approaches.

Subjects

MeSH terms (MEDLINE)

Antibodies, MonoclonalMass SpectrometryIsoelectric FocusingWorkflowElectrophoresis, CapillaryProtein Processing, Post-TranslationalHumansCapillary Isoelectric Focusing

Author keywords

Biologic licensing applicationBiologicsCharge variant characterizationImaged capillary isoelectric focusing (icIEF)Mass spectrometry (MS)Post-translational modifications (PTMs)

Substances

Antibodies, Monoclonal

Authors and institutions

  • Visterra Inc, 275 second avenue, Waltham, Massachusetts 02451, United States.
  • SCIEX, Fremont, California 94538, United States.

ORCID profiles: Arnik Shah

Funding

  • Visterra Inc.

Cite

APA

Shah, A., Shah, P., Johnson, A., Bender, J., Gumerov, D., Ding, J., Mack, S., Stone, M. D., & Ostrowski, M. A. (2025). Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1021/jasms.5c00058

Vancouver

Shah A, Shah P, Johnson A, Bender J, Gumerov D, Ding J, et al. Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow. Journal of the American Society for Mass Spectrometry. 2025. doi:10.1021/jasms.5c00058

BibTeX
@article{Shah2025,
  author = {Shah, Arnik and Shah, Parth and Johnson, Alex and Bender, Jean and Gumerov, Dmitry and Ding, Jingwen and Mack, Scott and Stone, Matthew D and Ostrowski, Maggie A},
  title = {Accelerating Characterization of Therapeutic Antibodies: A Comparative Assessment of icIEF-UV/MS and the Traditional Fractionation Workflow},
  journal = {Journal of the American Society for Mass Spectrometry},
  year = {2025},
  doi = {10.1021/jasms.5c00058}
}
Start for free →